References
Adam D, Gahl K, von Gravenitz H et al (1998) Revidierte Empfehlungen zur Prophylaxe bakterieller Endokarditiden. Z Kardiol 87:566–568
Alfieri O, Maisano F, De Bonis M, Stefano PL, Torracca L, Oppizzi M, La Canna G (2001) The double-orifice technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg 122:674–681
Amato MC, Moffa PJ, Werner KE, Ramires JA (2001) Treatment decision in asymptomatic aortic valve stenosis: role of exercise testing. Heart 86:381–386
Avierinos J-F, Brown RD, Foley DA, Nkomo V, Petty GW, Scott C, Enriquez- Sarano M (2003) Cerebral ischemic events after diagnosis of mitral valve prolapse: a community-based study of incidence and predictive factors. Stroke 34:1339–1345
Bates SM, Greer IA, Hirsh J, Ginsberg JS (2004) Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126(3 Suppl):627S–644S
Bolen JL, Alderman EL (1976) Hemodynamic consequences of afterload reduction in patients with chronic aortic regurgitation. Circulation 53:879–883
Bonow RO, Lakatos E, Maron BJ, Epstein SE (1991) Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function. Circulation 84:1625–1635
Bonow RO, Carabello B, de Leon AC Jr et al (1998) ACC/AHA guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease). J Am Coll Cardiol 32:1486–1588
Butchart EG, Gohlke-Barwolf C, Antunes MJ et al (2005) Recommendations for the management of patients after heart valve surgery. Eur Heart J 26:2463–2471
Carpentier A (1983) Cardiac valve surgery “the “French correction” J Thorac Cardiovasc Surg 86:323–337
Cheitlin MD, Douglas PS, Parmley WW (1994) 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 2: acquired valvular heart disease. J Am Coll Cardiol 24:874–880
Chen CR, Cheng TO, Huang T, Zhou YL, Chen JY, Huang YG, Li HJ (1996) Percutaneous balloon valvuloplasty for pulmonary stenosis in adolescents and adults. N Engl J Med 335:21–25
Chockalingam A, Venkatesan S, Subramaniam T et al (2004) Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis (SCOPE-AS). Am Heart J 147:E19
Connolly HM, Oh JK, Orszulak TA et al (1997) Aortic valve replacement for aortic stenosis with severe left ventricular dysfunction. Prognostic indicators. Circulation 95:2395–2400
Connolly HM, Oh JK, Schaff HV, Roger VL, Osborn SL, Hodge DO, Tajik AJ (2000) Severe aortic stenosis with low transvalvular gradient and severe left ventricular dysfunction: result of aortic valve replacement in 52 patients. Circulation 101:1940–1946
Coulshed N, Epstein EJ, McKendrick CS, Galloway RW, Walker E (1970) Systemic embolism in mitral valve disease. Br Heart J 32:26–34
Craige E (1957) Phonocardiographic studies in mitral stenosis. N Engl J Med 257:650–654
Daniel WG, Mügge A, Martin RP et al (1991) Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography. N Engl J Med 324:795–800
Das P, Rimington H, Chambers J (2005) Exercise testing to stratify risk in aortic stenosis. Eur Heart J 26:1309–1313
Davies SW, Gershlick AH, Balcon R (1991) Progression of valvar aortic stenosis: a long-term retrospective study. Eur Heart J 12:10–14
deFilippi CR, Willett DL, Brickner ME, Appleton CP, Yancy CW, Eichhorn EJ, Grayburn PA (1995) Usefulness of dobutamine echocardiography in distinguishing severe from nonsevere valvular aortic stenosis in patients with depressed left ventricular function and low transvalvular gradients. Am J Cardiol 75:191–194
Del Campo C, Sherman JR (2000) Tricuspid valve replacement: Results comparing mechanical and biological prostheses. Ann Thorac Surg 69:1295
Diker E, Aydogdu S, Ozdemir M et al (1996) Prevalence and predictors of atrial fibrillation in rheumatic valvular heart disease. Am J Cardiol 77:96–108
Discigil B, Dearani JA, Puga FJ, Schaff HV, Hagler DJ, Warnes CA, Danielson GK (2001) Late pulmonary valve replacement after repair of tetralogy of Fallot. J Thorac Cardiovasc Surg 121:344–351
Disse S, Abergel E, Berrebi A et al (1999) Mapping of a first locus for autosomal dominant myxomatous mitral-valve prolapse to chromosome 16 p11.2–p12.1. Am J Hum Genet 65: 1242–1251
Dubin AA, March HW, Chon K, Selzer A (1971) Longitudinal hemodynamic and clinical study of mitral stenosis. Circulation 44:381–389
Eagle KA, Guyton RA, Davidoff R et al (2004) American College of Cardiology; American Heart Association. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 110:e340–e437
Eslami M, Rahimtoola SH (2003) Prophylactic aortic valve replacement in older patients with mild aortic stenosis during coronary artery surgery. Am J Geriatr Cardiol 12:197–200
Evangelista A, Tornos P, Sambola A, Permanyer-Miralda G, Soler-Soler J (2005) Long-term vasodilator therapy in patients with severe aortic regurgitation. N Engl J Med 353:1342–1349
Faggiano P, Ghizzoni G, Sorgato A, Sabatini T, Simoncelli U, Gardini A, Rusconi C (1992) Rate of progression of valvular aortic stenosis in adults. Am J Cardiol 70:229–233
Filsoufi F, Aklog L, Adams DH, Byrne JG (2002) Management of mild to moderate aortic stenosis at the time of coronary artery bypass grafting. J Heart Valve Dis 11(Suppl 1):S45–S49
Flachskampf FA, Weyman AE, Gillam L, Liu CM, Abascal VM, Thomas JD (1990) Aortic regurgitation shortens Doppler pressure half-time in mitral stenosis: theoretical analysis, in vitro modelling, and clinical evidence. J Am Coll Cardiol 16:396–404
Freed LA, Levy D, Levina RA et al (1999) Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med 341:1–10
Freed LA, Acierno JS, Dai D et al (2003) A locus for autosomal dominant mitral valve prolapse on chromosome 11 p15.4. Am J Hum Genet 72:1551–1559
Fuster V, Ryden L, Asinger RW, American College of Cardiology/American Heart Association/European Society of Cardiology Board et al (2001) ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. J Am Coll Cardiol 38:1231–1266
Gao G, Wu Y, Grunkemeier GL, Furnary AP, Starr A (2004) Durability of pericardial versus porcine aortic valves. J Am Coll Cardiol 44:384–388
Gillinov AM, Cosgrove DM, Blackstone EH et al (1998) Durability of mitral valve repair for degenerative disease. J Thorac Cardiovasc Surg 116:734–743
Gillinov AM, Garcia MJ (2005) When is concomitant aortic valve replacement indicated in patients with mild to moderate stenosis undergoing coronary revascularization? Curr Cardiol Reports 7:101–104
Gilon D, Buonanno FS, Joffe MM, Leavitt M, Marshall JE, Kistler P, Levine RA (1999) Lack of evidence of an association between mitral valve prolapse and stroke in young patients. N Engl J Med 341:8–13
Gordon SP, Douglas PS, Come PC, Manning WJ (1992) Two-dimensional and Doppler echocardiographic determinants of the natural history of mitral valve narrowing in patients with rheumatic mitral stenosis: implications for follow-up. J Am Coll Cardiol 19:968–973
Greenberg B, Massie B, Bristow JD et al (1988) Long-term vasodilator therapy of chronic aortic insufficiency. A randomized double-blinded placebo controlled clinical trial. Circulation 78:92–103
Grover FL, Cohen DJ, Oprian C, Henderson WG, Sethi G, Hammermeister KE (1994) Determinants of the occurrence of and survival from prosthetic valve endocarditis. J Thorac Cardiovasc Surg 108:207–214
Hatle L, Angelsen B, Tromsdal A (1979) Noninvasive assessment of atrioventricular pressure half-time by Doppler ultrasound. Circulation 60:1096–1104
Hilton TC (2000) Aortic valve replacement for patients with mild to moderate aortic stenosis undergoing coronary artery bypass surgery. Clin Cardiol 23:141–147
Horstkotte D, Schulte HD, Niehues R, Klein RM, Piper C, Strauer BE (1993) Diagnostic and therapeutic considerations in acute, severe mitral regurgitation: experience in 42 consecutive patients entering the intensive care unit with pulmonary edema. J Heart Valve Dis 2:512–522
Horstkotte D, Piper C, Niehues R, Wiemer M, Schultheiss HP (1995) Late prosthetic valve endocarditis. Eur Heart J 16(Suppl B):39–47
Horstkotte D, Follath F, Gutschik E et al; Task Force Members on Infective Endocarditis of the European Society of Cardiology (2004) Guidelines on Prevention, Diagnosis, and Treatment of Infective Endocarditis. Eur Heart J 25:267–276
Iung B, Garbarz E, Michaud P et al (1999) Late results of percutaneous mitral commissurotomy in a series of 1024 patients: analysis of late clinical deterioration: frequency, anatomical findings, and predictive factors. Circulation 99:3272–3278
Iung B, Gohlke-Bärwolf C, Tornos P et al; on behalf of the Working Group on Valvular Heart Disease (2002) Working Group Report: Recommendations on the management of the asymptomatic patient with valvular heart disease. Eur Heart J 23:1253–1266
Iung B, Baron G, Butchart EG et al (2003) A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J 24:1231–1243
Iung B, Nicoud-Houel A, Fondard O et al (2004) Temporal trends in percutaneous mitral commissurotomy over a 15-year period. Eur Heart J 25(8):701–707
Kalmar P, Irrgang E; German Society for Thoracic and Cardiovascular Surgery (2004) Cardiac Surgery in Germany during 2003: a report by the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 52:312–317
Kar AK, Rath PC, Sinha N, Haridas KK, Dasbiswas A, Kerkar P, Kumar R; Non-Coronary Cardiac Intervention Registry of India; Cardiological Society of India (2003) Noncoronary cardiac interventions. The 3rd report of the Non-Coronary Cardiac Interventions Registry of India. The Cardiological Society of India. Indian Heart J 55:658–562
Karagounis A, Valencia O, Chandrasekaran V, Smith J, Brecker S, Jahangiri M (2004) Management of patients undergoing coronary artery bypass graft surgery with mild to moderate aortic stenosis. J Heart Valve Dis 13:369–373
Körtke H, Gohlke-Bärwolf C, Heik SCW, Horstkotte D, Körfer R (1998) Empfehlungen zum INR — Selbstmanagement bei oraler Antikoagulation. Z Kardiol 87:983–985
Lancellotti P, Lebrun F, Pierard LA (2004) Determinants of exercise-induced changes in mitral regurgitation in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 42:1921–1928
Langer F, Aicher D, Kissinger A, Wendler O, Lausberg H, Fries R, Schafers HJ (2004) Aortic valve repair using a differentiated surgical strategy. Circulation 110, 11(Suppl 1):II67–I173
Leavitt JI, Coats MH, Falk RH (1991) Effects of exercise on transmitral gradient and pulmonary artery pressure in patients with mitral stenosis or a prosthetic mitral valve: a Doppler echocardiographic study. J Am Coll Cardiol 17:1520–1526
Leport C, and the Endocarditis Working Group of the International Society of Chemotherapy (1998) Antibiotic prophylaxis for infective endocarditis. Clin Microbiol Infect 4(Suppl 3):S56–S61
Levine HJ, Gaasch WH (1996) Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves. J Am Coll Cardiol 28:1083–1091
Lin M, Chiang HT, Lin SL, Chang MS, Chiang BN, Kuo HW, Cheitlin MD (1994) Vasodilator therapy in chronic asymptomatic aortic regurgitation: enalapril versus hydralazine therapy. J Am Coll Cardiol 24:1046–1053
Lindroos M, Kupari M, Heikkila J, Tilvis R (1993) Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 21:1220–1225
Lowes BD, Gill EA, Abraham WT, Larrain JR, Robertson AD, Bristow MR, Gilbert EM (1999) Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure. Am J Cardiol 83:1201–1205
Marks AR, Choong CY, Sanfilippo AJ, Ferre M, Weyman AE (1989) Identification of high-risk and low-risk subgroups of patients with mitral-valve prolapse. N Engl J Med 320:1031–1036
Martin RP, Rakowski H, Kleiman JH, Beaver W, London E, Popp RL (1979) Reliability and reproducibility of two dimensional echocardiographic measurement of the stenotic mitral valve orifice area. Am J Cardiol 43:560–568
Miller RR, Vismara LA, DeMaria AN, Salel AF, Mason DT (1976) Afterload reduction therapy with nitroprusside in severe aortic regurgitation: improved cardiac performance and reduced regurgitant volume. Am J Cardiol 38:564–567
Mohler ER 3rd, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS (2001) Bone formation and inflammation in cardiac valves. Circulation 103:1522–1528
Møller JE, Connolly HM, Rubin J, Seward JB, Modesto K, Pellikka PA (2003) Factors associated with progression of carcinoid heart disease. N Engl J Med 348:1005–1015
Monin JL, Quere JP, Monchi M et al (2003) Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation 108:319–324
Naber CK (2004) S2-Leitlinie zur Diagnostik und Therapie der infektiösen Endokarditis. Z Kardiol 93:1005–1021
Nasuti JF, Zhang PJ, Feldman MD et al (2004) Fibrillin and other matrix proteins in mitral valve prolapse syndrome. Ann Thorac Surg 77:532–536
Nishimura RA, McGoon MD, Shub C, Miller FA Jr, Ilstrup DM, Tajik AJ (1985) Echocardiographically documented mitral-valve prolapse: longterm follow-up of 237 patients. N Engl J Med 313:1305–1309
O’Brien KD, Reichenbach DD, Marcovina SM, Kuusisto J, Alpers CE, Otto CM (1996) Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of ‘degenerative-valvular aortic stenosis. Arterioscler Thromb Vasc Biol 16:523–532
O’Brien KD, Zhao XQ, Shavelle DM et al (2004) Hemodynamic effects of the angiotensin-converting enzyme inhibitor, ramipril, in patients with mild to moderate aortic stenosis and preserved left ventricular function. J Investig Med 52:185–191
Odell JA, Mullany CJ, Schaff HV, Orszulak TA, Daly RC, Morris JJ (1996) Aortic valve replacement after previous coronary artery bypass grafting. Ann Thorac Surg 62:1424–1430
Otto CM, Pearlman AS, Gardner CL (1989) Hemodynamic progression of aortic stenosis in adults assessed by Doppler echocardiography. J Am Coll Cardiol 13:545–550
Otto CM, Burwash IG, Legget ME et al (1997) Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation 95:2262–2270
Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS (1999) Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 341:142–147
Palacios IF, Sanchez PL, Harrell LC, Weyman AE, Block PC (2002) Which patients benefit from percutaneous mitral balloon valvuloplasty? Circulation 105:1465–1471
Pellikka PA, Nishimura RA, Bailey KR, Tajik AJ (1990) The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis. J Am Coll Cardiol 15:1012–1017
Peter M, Hoffmann A, Parker C, Luscher T, Burckhardt D (1993) Progression of aortic stenosis. Role of age and concomitant coronary artery disease. Chest 103:1715–1719
Pierard LA, Lancellotti P (2004) The role of ischemic mitral regurgitation in the pathogenesis of acute pulmonary edema. N Engl J Med 351:1627–1634
Piper C, Wiemer M, Schulte HD, Horstkotte D (2001) Stroke is not a contraindication for urgent valve replacement in acute infective endocarditis. J Heart Valve Dis 10:703–711
Piper C, Körfer R, Horstkotte D (2001) Prosthetic valve endocarditis. Heart 85:590–593
Piper C, Hetzer R, Körfer F, Bergemann R, Horstkotte D (2002) The importance of secondary mitral valve involvement in primary aortic valve endocarditis: the mitral kissing vegetation. Eur Heart J 23:79–86
Rahimtoola SH, Durairaj A, Mehra A, Nuno I (2002) Current evaluation and management of patients with mitral stenosis. Circulation 106:1183–1188
Rahimtoola SH (2003) Choice of prosthetic heart valve for adult patients. J Am Coll Cardiol 41:893–904
Roger VL, Tajik AJ, Bailey KR, Oh JK, Taylor CL, Seward JB (1990) Progression of aortic stenosis in adults: new appraisal using Doppler echocardiography. Am Heart J 119:331–338
Rosenhek R, Binder T, Porenta G et al (2000) Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 343:611–617
Rosenhek R, Maurer G, Baumgartner H (2002) Should early elective surgery be performed in patients with severe but asymptomatic aortic stenosis? Eur Heart J 23:1417–1421
Rosenhek R, Klaar U, Schwemper M et al (2004) Mild and moderate aortic stenosis. Natural history and risk stratification by echocardiography. Eur Heart J 25:199–205
Ross J Jr, Braunwald E (1968) Aortic stenosis. Circulation 38:61–77
Rowe JC, Bland EF, Sprague HB (1960) The course of mitral stenosis without surgery: ten and twenty years perspectives. Ann Intern Med 52:741–749
Salem DN, Stein PD, Al-Ahmad A, Bussey HI, Horstkotte D, Miller N, Pauker SG (2004) Antithrombotic therapy in valvular heart disease — native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126(Suppl 3):457S–482S
Sancaktar O, Kumbasar SD, Semiz E, Yalcinkaya S (1998) Late results of combined percutaneous balloon valvuloplasty of mitral and tricuspid valves. Cathet Cardiovasc Diagn 45:246–250
Schon HR, Dorn R, Barthel P, Schomig A (1994) Effect of 12 months quinapril therapy in asymptomatic patients with chronic aortic regurgitation. J Heart Valve Dis 3:500–509
Scognamiglio R, Rahimtoola SH, Fasoli G, Nistri S, Dalla Volta S (1994) Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. N Engl J Med 331:689–694
Singh JP, Evans JC, Levy D et al (1999) Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol 83:897–802
Smith WT, Ferguson TB, Ryan T, Landolfo CK, Peterson ED (2004) Should coronary artery bypass surgery patients with mild or moderate aortic stenosis undergo concomitant aortic valve replacement? A decision analysis approach to the surgical dilemma. J Am Coll Cardiol 44:1241–1247
Stewart BF, Siscovick D, Lind BK et al (1997) Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 29:630–634
The Task Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cardiology (2003) Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J 24:761–781
Thomas JD, Wilkins GT, Choong CY, Abascal VM, Palacios IF, Block PC, Weyman AE (1988) Inaccuracy of mitral pressure half-time immediately after percutaneous mitral valvotomy: dependence on transmitral gradient and left atrial and ventricular compliance. Circulation 78:980–993
Turina J, Hess O, Sepulcri F, Krayenbuehl HP (1987) Spontaneous course of aortic valve disease. Eur Heart J 8:471–483
Vitale N, De Feo M, De Santo LS, Pollice A, Tedesco N, Cotrufo M (1999) Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 33:1637–1641
Vuille C, Nidorf M, Weyman AE, Picard MH (1994) Natural history of vegetations during successful medical treatment of endocarditis. Am Heart J 128:1200–1209
Wagner S, Selzer A (1982) Patterns of progression of aortic stenosis: a longitudinal hemodynamic study. Circulation 65:709–712
Wu WC, Aziz GF, Sadaniantz A (2004) The use of stress echocardiography in the assessment of mitral valvular disease. Echocardiography 21:451–458
Yee ES, Khonsari S (1989) Rightsided infective endocarditis: valvuloplasty, valvectomy or replacement. J Cardiovasc Surg (Torino) 30:744–748
Author information
Authors and Affiliations
Corresponding author
Additional information
Herausgegeben vom Vorstand der Deutschen Gesellschaft für Kardiologie — Herz- und Kreislaufforschung e.V. Bearbeitet im Auftrag der Kommission für Klinische Kardiologie G. Ertl, D. Andresen, M. Böhm, M. Borggrefe, J. Brachmann, F. de Haan, A. Osterspey, S. Silber, H. J. Trappe außerdem G. Arnold, H.M. Hoffmeister, E. Fleck
Diese Leitlinie ist eine Stellungnahme der Deutschen Gesellschaft für Kardiologie — Herz- und Kreislaufforschung e.V. (DGK), die den gegenwärtigen Erkenntnisstand wiedergibt und Ärzten und ihren Patienten die Entscheidungsfindung erleichtern soll. Eine Leitlinie ersetzt nicht die ärztliche Evaluation des individuellen Patienten und die Anpassung der Diagnostik und Therapie an dessen spezifische Situation.
Die Entwicklung Evidenz-basierter Leitlinien ist durch eine systematische Aufarbeitung und Zusammenstellung der besten verfügbaren wissenschaftlichen Evidenz gekennzeichnet. Die Herleitung des in der Leitlinie vorgeschlagenen Vorgehens ergibt sich allein aus der wissenschaftlichen Evidenz von Studien, wobei randomisierte, kontrollierte Studien bevorzugt werden. Der Zusammenhang zwischen der jeweiligen Empfehlung und der zugehörigen Evidenz-Stufe ist gekennzeichnet (s. Tab. 1).
Rights and permissions
About this article
Cite this article
Daniel, W.G., Baumgartner, H., Gohlke-Bärwolf, C. et al. Klappenvitien im Erwachsenenalter. Clin Res Cardiol 95, 620–641 (2006). https://doi.org/10.1007/s00392-006-0458-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-006-0458-8